HomeNAMSW • NASDAQ
add
NewAmsterdam Pharma Co
Previous close
$7.55
Day range
$7.45 - $7.78
Year range
$5.45 - $16.00
Market cap
2.03B USD
Avg Volume
2.35K
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.98M | 112.56% |
Operating expense | 71.90M | 26.41% |
Net income | -39.53M | 57.85% |
Net profit margin | -1.33K | 80.17% |
Earnings per share | -0.30 | 69.43% |
EBITDA | -68.87M | -24.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 808.48M | 68.03% |
Total assets | 818.41M | 67.55% |
Total liabilities | 41.05M | -46.45% |
Total equity | 777.36M | — |
Shares outstanding | 112.27M | — |
Price to book | 1.09 | — |
Return on assets | -20.48% | — |
Return on capital | -22.44% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -39.53M | 57.85% |
Cash from operations | -36.47M | 33.21% |
Cash from investing | 2.86M | 841.56% |
Cash from financing | 6.52M | -96.71% |
Net change in cash | -23.32M | -116.58% |
Free cash flow | -73.44M | -316.91% |
About
Founded
2019
Website
Employees
77
